cp wire

CP Wire Articles

Lumenis announced the publication of meaningful new clinical evidence for its surgical intervention for patients with... read more

Tue, 03/27/18 - 09:44 am
CP Staff

Preliminary results for the TOPACIO trial (a Phase I/II trial) of Tesoro’s Zejula (niraparib) with Keytruda in women with platinum-resistant... read more
Mon, 03/26/18 - 02:38 pm

Ampio Pharmaceuticals announced today some partial results of a follow-up (3.4-3.7 years) trial evaluating Ampion™ for pain due to osteoarthritis-of-the-knee after the last Ampion or saline... read more

Mon, 03/26/18 - 09:45 am
CP Staff

Novartis announced Thursday that the full results from the Phase III EXPAND study of oral, once-daily siponimod (BAF312) in secondary progressive multiple sclerosis (SPMS) were published in the... read more

Fri, 03/23/18 - 12:47 am
CP Staff

In July of 2012, Sanford Heisler Sharp, LLP filed a gender discrimination lawsuit against Forest Labs (now part of Allergan), on behalf of eleven female sales reps, as well as a class... read more
Thu, 03/22/18 - 03:44 pm

The House passed the so called “Right to Try” bill on Wednesday evening. The vote was roughly along party lines, 267-149 with 35 Democrats supporting the bill and 2 Republicans opposed.

... read more

Thu, 03/22/18 - 09:15 am
CP Staff

AOBiome Therapeutics today  announced clinical findings from Part 1 of a Phase 1b/2a clinical trial of the Company's first-in-class Ammonia Oxidizing Bacteria (AOB) product candidate for... read more

Wed, 03/21/18 - 10:07 am
CP Staff

Sun Pharma announced today that the U.S. Food and Drug Administration (FDA) has approved ILUMYA™ (tildrakizumab-asmn) for the treatment of adults with moderate-to-severe plaque psoriasis who are... read more

Wed, 03/21/18 - 09:44 am
CP Staff

Little more than 24 hours after announcing a proposed public offering of 9,000,000 shares of common stock, Proteostasis Therapeutics announced that it is withdrawing the offering. The reason given... read more

Tue, 03/20/18 - 10:35 pm
CP Staff

Inovio announced today that it closed an agreement providing ApolloBio Corp. (NEEQ:430187) with the exclusive right to develop, manufacture and commercialize VGX-3100, Inovio’s DNA immunotherapy... read more

Tue, 03/20/18 - 10:11 am
CP Staff

Cotinga announced that it has submitted an updated clinical package to regulatory authorities to expand its ongoing Phase 1 trial of COTI-2. The protocol amendment will expand the clinical trial... read more

Tue, 03/20/18 - 09:43 am
CP Staff

S2516: Alternatives to Opioids (ALTO) in the Emergency Department Act

This bill was introduced by Senator Corey Booker (D-NJ) on 3/7/2018 and cosponsored by Senators... read more

Mon, 03/19/18 - 01:20 pm
CP Staff

This bill was introduced by David P Roe (R-TN) on 3/15/2018. The full text of the bill has yet to be posted. The full title of the bill is:

H.R.5298 - To amend the Controlled... read more

Mon, 03/19/18 - 12:34 pm
CP Staff

OPKO Health Announces Landmark Study Showing 4Kscore® Test is Strong Predictor of Prostate Cancer Mortality Published in European Urology

OPKO Health, Inc. (NASDAQ:OPK) today announced that... read more

Fri, 03/16/18 - 11:06 am
CP Staff

 The data will be presented at the B. Riley FBR Inaugural China Healthcare Investing & Partnering Symposium (CHIPS), to be held March 15-17, 2018 at the Intercontinental Hotel in Hangzhou... read more

Fri, 03/16/18 - 09:35 am
CP Staff

The FDA has granted Rare Pediatric Disease Designation for the ABO-202 program (AAV-CLN1), an AAV-based gene therapy for the treatment of CLN1 disease (infantile and late infantile onset... read more

Thu, 03/15/18 - 10:53 pm
CP Staff

This act, sponsored by Louise Slaughter D-NY,  directs the Attorney General to establish a stewardship program to facilitate the collection and disposal of prescription medication. The apparent... read more

Thu, 03/15/18 - 09:36 am
CP Staff

The MasSpec Pen has been awarded the SXSW Interactive Innovation Award in the Health, Med and Biotech category. The MasSpec Pen is a handheld device that allows surgeons to identify cancerous... read more

Wed, 03/14/18 - 03:55 pm
CP Staff

The “Right to Try” bill failed a vote in the House on Tuesday. After being unveiled over the weekend, the bill was rushed to a vote using a procedure normally reserved for uncontroversial bills.... read more

Wed, 03/14/18 - 11:28 am
CP Staff

This Tuesday, the House will vote on a revised version of the “Right to Try” Act that gives critically ill patients access to experimental medications.

Last summer... read more

Mon, 03/12/18 - 01:14 pm
CP Staff


current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.